Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

Clinical trial NCT07206849 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07206849
Sponsor: Nationwide Children's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High Grade Glioma (HGG) of the Brain With BRAF Aberration High Grade Glioma (III or IV)Diffuse Intrinsic Pontine Glioma High Grade Glioma WHO Grade 3 Glioma WHO Grade 4 Glioma Metastatic Brain Tumor

Start date: 2026-11-01
Primary completion: 2030-11-01
Enrollment: 79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.